KR20160097854A - Anti-wrinkle and anti-skin sagging cosmetic composition containing extracts of hypsizigus marmoreus - Google Patents

Anti-wrinkle and anti-skin sagging cosmetic composition containing extracts of hypsizigus marmoreus Download PDF

Info

Publication number
KR20160097854A
KR20160097854A KR1020150020248A KR20150020248A KR20160097854A KR 20160097854 A KR20160097854 A KR 20160097854A KR 1020150020248 A KR1020150020248 A KR 1020150020248A KR 20150020248 A KR20150020248 A KR 20150020248A KR 20160097854 A KR20160097854 A KR 20160097854A
Authority
KR
South Korea
Prior art keywords
skin
cosmetic composition
weight
mushroom
present disclosure
Prior art date
Application number
KR1020150020248A
Other languages
Korean (ko)
Other versions
KR101821738B1 (en
Inventor
김선태
양승호
Original Assignee
김선태
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김선태 filed Critical 김선태
Priority to KR1020150020248A priority Critical patent/KR101821738B1/en
Publication of KR20160097854A publication Critical patent/KR20160097854A/en
Application granted granted Critical
Publication of KR101821738B1 publication Critical patent/KR101821738B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Cosmetics (AREA)

Abstract

The present disclosure relates to an anti-wrinkle and anti-skin sagging cosmetic composition prepared by comprising a Hypsizigus marmoreus extract as an active component. An anti-skin sagging cosmetic composition using a Hypsizigus marmoreus extract according to an exemplary embodiment of the present disclosure comprises 0.5 to 10.0 percentages by weight of a Hypsizigus marmoreus extract with a molecular weight of 200,000 to 500,000. Accordingly, an anti-skin sagging cosmetic composition using a Hypsizigus marmoreus extract according to an exemplary embodiment of the present disclosure improves skin wrinkles by moisturizing and antioxidant effects of free and constituent amino acid compounds which are contained in Hypsizigus marmoreus in large amounts. Further, an anti-skin sagging cosmetic composition using a Hypsizigus marmoreus extract according to an exemplary embodiment of the present disclosure gives a lifting effect of pulling sagged skin by enabling crude protein that is various peptide complexes comprising low molecular weight beta-glucan to strengthen immunity and inhibit promotion/decomposition of collagen synthesis internally in the skin.

Description

해송이버섯 추출물을 이용한 주름개선 및 피부 처짐 개선용 화장료 조성물{ANTI-WRINKLE AND ANTI-SKIN SAGGING COSMETIC COMPOSITION CONTAINING EXTRACTS OF HYPSIZIGUS MARMOREUS}TECHNICAL FIELD The present invention relates to a cosmetic composition for improving wrinkles and skin defects using a mushroom extract of Haemophilus sp.

본 개시(Disclosure)는 화장료 조성물에 관한 것으로서, 보다 구체적으로 해송이버섯 추출물을 유효성분으로 포함하여 제조된 주름개선 및 피부 처짐 개선용 화장료 조성물에 관한 것이다.Disclosure of the present invention relates to a cosmetic composition, and more particularly, to a cosmetic composition for improving wrinkles and skin defects, which is produced by incorporating mushroom extract as an active ingredient.

여기서는, 본 발명에 관한 배경기술이 제공되며, 이들이 반드시 공지기술을 의미하는 것은 아니다(This section provides background information related to the present disclosure which is not necessarily prior art).Herein, the background art relating to the present invention is provided, and they are not necessarily referred to as known arts.

피부의 노화 기작을 규명하기 위한 여러 연구들이 있었고, 그 결과로 여러 가지 피부 노화의 원인들이 밝혀졌다. There have been several studies to elucidate the aging mechanism of skin, and as a result, the causes of various skin aging have been revealed.

피부가 온도의 변화, 습도의 저하 또는 바람 등에 의해 건조하게 되면 외부에 대한 방어벽으로서의 피부 생리활성이 저하되어 노화가 촉진된다. 또한, 유해 활성산소종 또는 자유라디칼에 피부가 노출되면 체내의 산화 작용에 이해 과산화 지질이 생성되고 피부를 구성하는 여러 단백질들의 변형을 유발하게 된다. When the skin is dried by a change in temperature, a decrease in humidity, or wind, the skin physiological activity as a barrier against the outside is lowered and aging is promoted. If exposed to harmful reactive oxygen species or free radicals, oxidative action of the body causes lipid peroxidation, which leads to deformation of various proteins constituting the skin.

한편 피부 진피의 대부분 (피부 전제 건조중량의 약 70~80%)을 차지하는 콜라겐(Collagen)과 신축성이 큰 엘라스틴(Elastin) 단백질은 섬유아세포에서 생성되는 주요 단백질로 피부 진피층에서 피부의 기계적 견고성, 조직의 결합력 및 탄력성등에 관여한다(Journal of American academy of dermatology, 21:610-613(1989)). 콜라겐은 연령이 증가할수록, 그리고 자외선에 노출이 많이 될수록 양적 감소를 보인다. 콜라겐은 형태와 구조적 특징에 따라서 분류되는데, 이들 중에서 가장 특징이 잘 알려진 것은 타입 I, II, III 그리고 IV이다.Collagen and elastic elastin, which occupy most of the skin dermis (about 70-80% of the dry weight of the skin), are the main proteins produced by fibroblasts. These include the mechanical durability of the skin, , And the like (Journal of American Academy of Dermatology, 21: 610-613 (1989)). Collagen shows a quantitative decrease with increasing age and exposure to ultraviolet light. Collagen is classified according to its morphological and structural characteristics, among which the most well characterized are types I, II, III and IV.

콜라겐 타입 I, III은 진피층의 세포 간 지질의 구성성분을 이루고 콜라겐 타입 IV는 DEJ(Dermal Epidermal Junction)의 주요 구성물질이 된다. DEJ는 피부의 표피층과 진피층 사이에 위치하여 두 층간의 물질 투과와 수송을 조절해주며 인접한 피부 세포의 분화를 조절하며 피부의 견고성을 유지시켜준다.Collagen types I and III constitute the intercellular lipids of the dermis and Collagen type IV is the main constituent of DEJ (Dermal Epidermal Junction). DEJ is located between the epidermis and the dermis of the skin to control the permeation and transport of the material between the two layers. It regulates the differentiation of adjacent skin cells and maintains the firmness of the skin.

엘라스틴은 무정형의 기질에 미원섬유(Microfibrils)들이 박혀 있는 형태를 띠고 있는 탄력섬유로 고무와 같이 매우 낮은 탄성계수를 가지고 있어서, 작은 힘에 의해서도 쉽게 변형되고, 또 그 힘이 제거되었을 때는 쉽게 원형으로 되돌아 오는 성질을 가지고 있다. Elastin is an elastic fiber with a microfibrils embedded in an amorphous matrix. It has a very low elastic modulus such as rubber, so it can easily be deformed by a small force and easily deformed when it is removed. It has the property of coming back.

엘라스틴은 라이신에서 유래한 데스모신(Desmosine)과 아이소데스모신(Isodesmosine)이라는 탄력섬유에서만 발견되는 아주 독특한 아미노산으로 구성되어 있고 이러한 아미노산들이 긴 펩타이드 사슬 안에서 가교 (Cross-links)를 형성하여 엘라스틴으로 하여금 고무와 같은 성질을 갖게 한다.Elastin is made up of a very unique amino acid found only in the elastic fibers of lysine, desmosine and isodesmosine, and these amino acids form cross-links in long peptide chains, Rubber-like properties.

한편, 피부 노화와 탄력저하는 자외선 등에 이한 피부세포(섬유아세포)의 약화로 콜라겐과 엘라스틴의 생성저하 및 파괴에 의해 유발된다. 자외선 등에 피부 내에 콜라게나제(Collagenase)와 엘라스타제(Elastase)가 발현되며 이 효소는 피부내의 정상적인 콜라겐과 엘라스틴을 분해하여 피부 탄력저하를 가져온다.On the other hand, skin aging and reduction in elasticity are caused by degradation and destruction of collagen and elastin due to weakening of skin cells (fibroblasts) due to ultraviolet rays and the like. Collagenase and elastase are expressed in the skin such as ultraviolet rays, and this enzyme breaks down normal collagen and elastin in the skin, resulting in skin elasticity deterioration.

피부탄력을 증대시키는 것과 관련된 특허들을 살펴보면, 레구미노사 종자 (Leguminosae Seeds)에서 얻어진 단백질분획은 탄력증대효과를 나타내며 (미국특허 제5,322,839호), 맥아추출물 (Malt extract)등을 포함하는 조성물은 콜라게나제를 억제하는데 응용되고 있으며(일본특허 1995-105693호), 콜라게나제 또는 엘라스타제의 억제제로 카르바민산 펩티드 (Peptidyl carbamates), 티오카르바민산 펩티드(Peptidyl thiocarbamates), 하이드록사메이트(Hydroxamates), 세팔로스포린(Cephalosporin), 설포산염(Sulphonate salts)등을 함유하는 화장료 조성물(미국특허 제5,614,489호)등이 있다. The protein fractions obtained from Leguminosae Seeds exhibit an elasticity-enhancing effect (U.S. Patent No. 5,322,839), compositions containing malt extract and the like are useful as collagenase Peptidyl carbamates, peptidyl thiocarbamates, hydroxamates (hydroxamates), hydroxamates (hydroxamates), and the like. ), Cephalosporin, Sulphonate salts and the like (U.S. Patent No. 5,614,489).

이러한 종래기술은, 피부탄력 증대효과를 나타내기 위해 단순히 콜라게나제의 활성을 억제시키거나 또는 엘라스타제의 활성을 억제한 것이다. 이러한 종래기술은, 진피층에 한정되게 작용하여 그 기능의 극대화를 가져오지 못할 뿐 아니라 즉각적인 리프팅(피부 탄력 개선) 효과가 미미한 게 사실이다.Such prior art techniques merely inhibit the activity of collagenase or inhibit the activity of elastase to exhibit skin elasticity increasing effect. These conventional techniques are limited to the dermal layer and thus do not maximize their function, and the effect of immediate lifting (skin elasticity improvement) is minimal.

본 개시는, 천연재료인 해송이버섯을 이용하여 효율적으로 보습력을 유지시키고, 활성산소 등과 같은 다양한 산화적 스트레스에 의한 피부노화현상을 최소화함은 물론, 해송이버섯이 함유하고 있는 다양한 생리활성물질을 이용하여 손상된 피부를 치유/개선하여 궁극적으로는 즉각적인 주름개선 및 리프팅 효과를 발휘하는 해송이버섯 추출물을 이용한 주름개선 및 피부 처짐 개선용 화장료 조성물의 제공을 일 목적으로 한다.The present disclosure relates to a method for preventing the aging of skin caused by various oxidative stresses such as active oxygen and the like by maintaining the moisture retention efficiently by using natural materials such as sea grass and mushrooms and also by using various physiologically active substances And to provide a cosmetic composition for improving wrinkles and skin defects by using a mushroom extract of the present invention which exhibits immediate wrinkle improvement and lifting effect by ultimately healing / repairing damaged skin.

상기한 과제의 해결을 위해, 본 개시의 일 실시형태에 따른 해송이버섯 추출물을 이용한 주름개선 및 피부 처짐 개선용 화장료 조성물은, 분자량이 200,000 ~ 500,000인 해송이버섯 추출물 0.5~10.0중량%를 함유한다. In order to solve the above-mentioned problems, the cosmetic composition for improvement of wrinkles and skin defilement using a mushroom extract according to one embodiment of the present invention contains 0.5 to 10.0% by weight of a sea mushroom extract having a molecular weight of 200,000 to 500,000 do.

본 개시의 일 실시형태에 따른 해송이버섯 추출물을 이용한 주름개선 및 피부 처짐 개선용 화장료 조성물에 있어서, 바셀린 7.0중량%, 유동파라핀 5.0중량%, 밀납 2.0중량%, 폴리소르베이트60 2.0중량%, 소르비탄세스퀴올레이트 2.5중량%, 스쿠알란 3.0중량%, 프로필렌글라이콜 6.0중량%, 글리세린 4.0중량%, 트리에탄올아민 0.5중량%, 카르복시비닐폴리머 0.5중량%, 토코페릴아세테이트 0.1중량% 및 정제수 55~65중량%을 포함하는 것을 특징으로 한다.In the cosmetic composition for improvement of wrinkles and skin deflection improvement using a mushroom extract according to one embodiment of the present disclosure, 7.0% by weight of petroleum jelly, 5.0% by weight of liquid paraffin, 2.0% by weight of wax, 2.0% by weight of polysorbate 60, 2.5 weight percent of sorbitan sesquioleate, 3.0 weight percent squalane, 6.0 weight percent propylene glycol, 4.0 weight percent glycerin, 0.5 weight percent triethanolamine, 0.5 weight percent carboxyvinyl polymer, 0.1 weight percent tocopheryl acetate, By weight and 65% by weight.

본 개시의 일 실시형태에 따른 해송이버섯 추출물을 이용한 주름개선 및 피부 처짐 개선용 화장료 조성물에 있어서, 상기 해송이버섯 추출물은, 건조된 해송이버섯을 설정된 극성 추출 용매에 30~70℃의 온도 및 5~20시간 동안 침적(submerge)하여 추출되는 것을 특징으로 한다.A cosmetic composition for improving wrinkles and skin defects using a mushroom extract according to an embodiment of the present disclosure is characterized in that the mushroom extract of the present invention is characterized in that the dried mushroom is dried at a temperature of 30 to 70 DEG C And then submerged for 5 to 20 hours.

본 개시의 일 실시형태에 따른 해송이버섯 추출물을 이용한 주름개선 및 피부 처짐 개선용 화장료 조성물에 있어서, 상기 설정된 극성 추출 용매는, 상기 건조된 해송이버섯의 중량의 2~10배로 마련되는 것을 특징으로 한다.In the cosmetic composition for improving wrinkles and skin defilement using a mushroom extract according to an embodiment of the present disclosure, the set polar solvent for extracting is preferably 2 to 10 times the weight of the mushroom .

본 개시의 일 실시형태에 따른 해송이버섯 추출물을 이용한 주름개선 및 피부 처짐 개선용 화장료 조성물에 있어서, 상기 설정된 극성 추출 용매는, 탄소수 1 내지 4의 저급 알코올, 정제수 또는 이들의 혼합물 중 어느 하나로 마련되는 것을 특징으로 한다.In the cosmetic composition for improving wrinkles and skin defects using a mushroom extract according to one embodiment of the present disclosure, the polarity extraction solvent may be any one selected from the group consisting of a lower alcohol having 1 to 4 carbon atoms, purified water, or a mixture thereof .

본 개시의 일 실시형태에 따른 해송이버섯 추출물을 이용한 주름개선 및 피부 처짐 개선용 화장료 조성물에 의하면, 해송이버섯에 다량 함유되어 있는 유리 및 구성아미노산화합물과 페놀화합물의 보습효과 및 항산화효과에 의해 피부주름을 개선 시켜주며, 저분자 베타글루칸을 포함하는 다양한 펩타이드 복합체인 조단백질이 피부 내적으로 면역력강화와 콜라겐 합성 촉진/분해를 억제하여 처진 피부를 당겨주는 리프팅 효과를 부여한다.According to the cosmetic composition for improvement of wrinkle and skin sagging using the mushroom extract according to one embodiment of the present disclosure, the moisturizing effect and the antioxidant effect of the glass and the constituent amino acid compound and the phenolic compound, It improves skin wrinkles. Crude protein, which is a complex of various peptide complexes including low-molecular-weight beta-glucan, strengthens the skin intrinsically and inhibits collagen synthesis promotion / decomposition.

이하, 첨부된 도면을 참조하여 본 개시에 따른 해송이버섯 추출물을 이용한 주름개선 및 피부 처짐 개선용 화장료 조성물의 실시형태에 대하여 자세히 설명한다.Hereinafter, embodiments of a cosmetic composition for improving wrinkles and skin defects using the mushroom extract according to the present disclosure will be described in detail with reference to the accompanying drawings.

다만, 본 개시의 사상은 이하에서 살펴보는 실시형태에 의해 그 실시 가능 상태가 제한된다고 할 수는 없고, 본 개시의 사상을 이해하는 당업자는 동일한 기술적 사상의 범위 내에 포함되는 다른 실시 예를 이용하여 용이하게 제안할 수 있을 것이나, 이 또한 본 발명의 기술적 사상에 포함된다고 할 것이다. It should be understood, however, that the scope of the present disclosure is not limited by the embodiments described below, and that those skilled in the art, having the benefit of the teachings of this disclosure, It will be easily suggested, but this will also be included in the technical idea of the present invention.

또한, 본 명세서 또는 청구범위에서 사용되는 용어는 설명의 편의를 위하여 선택한 개념으로, 본 개시의 기술적 내용을 파악함에 있어서 본 개시의 기술적 사상에 부합되는 의미로 적절히 해석되어야 할 것이다. It is to be understood that the terms used in the present specification or claims are selected for convenience of explanation and should be interpreted appropriately in accordance with the technical idea of the present disclosure when grasping the technical contents of the present disclosure.

본 개시에 따른 해송이버섯 추출물을 이용한 주름개선 및 피부 처짐 개선용 화장료 조성물은 해송이버섯 추출물을 유효성분으로 함유한다.The cosmetic composition for improving wrinkles and skin defects using the mushroom extract according to the present invention contains the mushroom extract as an active ingredient .

본 개시에 있어서, 해송이버섯 추출물은, 전체 화장료 조성물에 대하여 0.5~10.0중량%로 함유된다. 더욱 바람직게는 해송이버섯 추출물이 1.0 내지 7.0 중량%로 함유된다. In the present disclosure, the sea mushroom extract is contained in an amount of 0.5 to 10.0% by weight based on the total cosmetic composition. More preferably, the sea tangle mushroom extract is contained in an amount of 1.0 to 7.0% by weight.

해송이버섯 추출물이 0.5 중량% 미만일 경우에는 화장료 조성물의 콜라겐 합성촉진, 콜라겐 분해억제 및 피부노화방지 효과가 미미하며, 10.0 중량%를 초과하여 투입할 경우에는 피부 트러블을 유발시킬 뿐 아니라 초과투입에 따른 상승 효과가 작아 경제적이지 못하다. When the extract is less than 0.5% by weight, the cosmetic composition promotes collagen synthesis, inhibits collagen degradation and aging of the skin are insignificant. When the extract is added in an amount exceeding 10.0% by weight, it causes skin trouble, The synergy effect is small and it is not economical.

본 개시에 있어서, 해송이버섯 추출물은, 해송이버섯 50중량%, 용매(에탄올) 49.2중량%, 방부제 0.8중량%를 혼합하여, 50℃ 수욕조에서 5시간 동안 중탕 추출하여 얻어질 수 있다.In the present disclosure, the sea mushroom extract can be obtained by mixing sea cucumber with 50% by weight of mushroom, 49.2% by weight of solvent (ethanol) and 0.8% by weight of preservative, and extracting with hot water for 5 hours in a 50 ° C water bath.

또한, 본 개시에 따른 해송이버섯 추출물을 이용한 주름개선 및 피부 처짐 개선용 화장료 조성물은, 바셀린 7.0중량%, 유동파라핀 5.0중량%, 밀납 2.0중량%, 폴리소르베이트60 2.0중량%, 소르비탄세스퀴올레이트 2.5중량%, 스쿠알란 3.0중량%, 프로필렌글라이콜 6.0중량%, 글리세린 4.0중량%, 트리에탄올아민 0.5중량%, 카르복시비닐폴리머 0.5중량%, 토코페릴아세테이트 0.1중량% 및 정제수 55~65중량%을 포함한다.The cosmetic composition for improving wrinkles and skin defilement using the mushroom extract according to the present invention contains 7.0% by weight of petrolatum, 5.0% by weight of liquid paraffin, 2.0% by weight of wax, 2.0% by weight of polysorbate 60, 2.5 weight percent of squalate, 3.0 weight percent squalane, 6.0 weight percent propylene glycol, 4.0 weight percent glycerin, 0.5 weight percent triethanolamine, 0.5 weight percent carboxyvinyl polymer, 0.1 weight percent tocopheryl acetate, and 55 weight percent to 65 weight percent purified water, .

한편, 본 개시에 있어서, 해송이버섯 추출물은 분자량이 200,000 ~ 500,000인 것으로 구비된다.On the other hand, in the present disclosure, the sea mushroom extract has a molecular weight of 200,000 to 500,000.

이에 의하면, 피부 단백질과 친화성이 좋고, 다른 조성성분을 흡수시키고 피부의 단백질과 단백질을 단단하게 응축시켜 피부에 얇은 단백질 막을 형성한다.According to this, it has good affinity with skin proteins, absorbs other constituents, and tightly condenses the proteins and proteins of the skin to form a thin protein film on the skin.

이에 의해, 즉각적으로 피부의 신장성을 줄여준다. 따라서 인지할 만한 피부 당김 효과를 부여한다. As a result, it immediately reduces skin elongation. Thus giving a noticeable skin pulling effect.

본 개시에 사용되는 해송이버섯은, 수분(Moisture) 7.15±0.55%, 조회분(Crude ash) 8.37±0.64%, 조단백질(Crude protein) 28.69±2.14%, 조지방(Crude lipid) 2.74±0.44%, 탄수화물(Carbohydrate) 53.04±2.75%의 성분비로 구성된다.The mushrooms used in the present invention were moisture content (Moisture) of 7.15 ± 0.55%, Crude ash of 8.37 ± 0.64%, crude protein (Crude protein) of 28.69 ± 2.14%, Crude lipid of 2.74 ± 0.44% Carbohydrate is composed of a composition ratio of 53.04 ± 2.75%.

또한, 본 개시에 사용되는 해송이버섯은, 면역체계를 활성화시키는 버섯류 유래 다당류인 베타글루칸 ((1,3), (1-4) and (1-6)-β-Glucan), 천연보습인자(NMF)라고 일컬어지는 61종의 유리 및 구조아미노산을 함유하고 있다. The mushroom used in the present invention is a mushroom-derived polysaccharide (1-3), (1-4) and (1-6) -β-Glucan) which activates the immune system, a natural moisturizing factor (NMF), which contains 61 kinds of free and structural amino acids.

여기서, 유리아미노산은 46.53mg/g, 구성아미노산은 204.87mg/g을 함유한다.Here, the free amino acid content is 46.53 mg / g and the constituent amino acid content is 204.87 mg / g.

본 개시에 따른 해송이버섯 추출물을 이용한 주름개선 및 피부 처짐 개선용 화장료 조성물은, 화장수, 에센스, 로션, 크림, 팩, 젤, 연고, 패취, 또는 분무제 등 다양한 제형으로 제조될 수 있고, 화장료의 사용 목적 등에 따라 유연화장수, 수렴화장수, 영양화장수, 아이크림, 영양크림, 마사지크림, 클렌징크림, 클렌징폼, 클렌징워터, 파우더, 에센스, 팩 등으로 제조될 수 있다. The cosmetic composition for improving wrinkles and skin defects using the mushroom extract of the present invention can be manufactured into various formulations such as lotion, essence, lotion, cream, pack, gel, ointment, patch, or spray, Eye cream, nutritional cream, massage cream, cleansing cream, cleansing foam, cleansing water, powder, essence, pack or the like according to the purpose of use.

다음으로, 본 개시에 있어서, 해송이버섯 추출물은 다음과 같이 제조할 수 있다. Next, in the present disclosure, the sea mushroom extract can be produced as follows.

먼저, 해송이버섯을 물로 깨끗이 세척한 후, 그늘에서 건조한다. First, the sea mushrooms are thoroughly washed with water, then dried in the shade.

다음으로, 건조한 해송이버섯을 추출용기를 이용하여 설정된 침적 온도에서 설정된 침적 시간 동안 가온하여 추출한다. Next, the dried sea cucumber is extracted by warming the mushroom for the set immersion time at the set immersion temperature using an extraction container.

추출 용매로는 탄소수 1 내지 4의 저급 알코올 또는 이들의 혼합용매로부터 선택된 극성용매를 사용할 수 있으며, 바람직하게는 에탄올이나 물을 첨가하여 추출한다.As the extraction solvent, a polar solvent selected from a lower alcohol having 1 to 4 carbon atoms or a mixed solvent thereof may be used. Preferably, ethanol or water is added to extract.

추출 용매의 양은 생약 건조중량의 2~10배로 한다. The amount of the extraction solvent is 2 to 10 times the dry weight of the herbal medicine.

추출방법은 중탕추출, 환류 냉각추출, 초음파추출 등의 추출방법을 사용할 수 있으며, 바람직하게는 중탕추출의 추출방법으로 1회 내지 3회 추출될 수 있다.An extraction method such as hot water extraction, reflux cooling extraction, ultrasonic extraction and the like can be used, and it can be extracted one to three times preferably by an extraction method of hot water extraction.

추출 용매로 상기 언급된 것이 특히 적합하지만 반드시 이에 한정되는 것은 아니며, 상기 언급한 용매와 물리화학적으로 성질이 유사한 다른 용매를 사용하여 해송이버섯 추출물을 제조할 수 있다. As the extraction solvent, the above-mentioned ones are particularly suitable, but the present invention is not limited thereto, and other mushroom extracts can be prepared using other solvents having physicochemical properties similar to those of the above-mentioned solvents.

설정된 침적온도는 30~70℃이며, 보다 바람직하게는 40~60℃이며, 가장 바람직하게는 50℃ 정도로 유지하는 것이 부패, 변색 및 변취의 예방에 가장 효과적이다.The settling temperature is preferably 30 to 70 DEG C, more preferably 40 to 60 DEG C, and most preferably 50 DEG C or so, which is most effective in preventing decay, discoloration and detachment.

설정된 침적 시간은 5~20시간이며, 바람직하게는 10시간이다.The settling time is 5 to 20 hours, preferably 10 hours.

한편, 추출된 해송이버섯 추출물은 여과되고 진공회전증발기 등을 이용하여 농축될 수 있다.On the other hand, the extracted mushroom extract can be filtered and concentrated using a vacuum rotary evaporator or the like.

여과는, 해송이버섯 추출물을 수득한 후, 거름종이 등을 이용하여 고형분을 제거하고, 현탁액을 원심분리시키고, 상층 액을 감압 여과할 수 있다. The filtration can be performed by removing the solid matter using a filter paper, centrifuging the suspension, and filtering the supernatant under reduced pressure, after obtaining the mushroom extract from the sea tangle.

농축은, 여과된 해송이버섯 추출물을 진공회전농축기로 20~100℃, 바람직하게는 50~70℃에서 감압 농축할 수 있다.Concentration can be achieved by concentration of the filtered sea bream mushroom extract in a vacuum rotary condenser at 20 to 100 ° C, preferably 50 to 70 ° C.

한편, 본 개시에 있어서, 해송이버섯 추출물은, 상술한 추출 용매에 의한 추출방법 외에, 일정한 분자량 컷-오프 값을 갖는 한외 여과막을 이용한 분리, 다양한 크로마토그래피(예를 들어 크기, 전하, 소수성 또는 친수성에 다른 분리를 위해 제작된 크로마토그래피에 의한 분리 등)에 의한 분리를 통해 얻어질 수 있음은 물론이다.
On the other hand, in the present disclosure, in addition to the extraction method using the above-described extraction solvent, the sea mushroom extract can be obtained by separation using an ultrafiltration membrane having a constant molecular weight cut-off value, various chromatography (for example, size, charge, Separation by chromatography produced for separation of hydrophilicity and the like, etc.).

이하에서는, 본 개시에 적용되는 해송이버섯 추출물이 피부에 미치는 효과에 대한 실험 결과를 설명한다.
Hereinafter, the experimental results on the effect of the mushroom extract on the skin applied to the present disclosure will be described.

해송이버섯Sea mushroom mushroom 추출물의 제조 Preparation of extract

본 개시에 있어서, 해송이버섯 추출물은, 해송이버섯 50g을 파쇄기에 곱게 파쇄하여 100% 에탄올 200ml에 침지시켜 50℃ 수욕조에서 5시간 동안 온탕하였다.In the present disclosure, the sea mushroom extract was prepared by crushing 50 g of the sea mushroom into a crusher, immersing it in 200 ml of 100% ethanol, and warming it in a 50 ° C water bath for 5 hours.

다음으로, 실온으로 냉각시키고, 거름종이로 여과하여 여과액을 취하였다.Next, the mixture was cooled to room temperature and filtered with a filter paper to obtain a filtrate.

다음으로, 질소를 사용하여 여과액에서 에탄올을 증발시켜 농축한 다음, 이를 10% 에탄올에 녹여 추출물을 제조하였다.
Next, the ethanol was evaporated from the filtrate using nitrogen, concentrated, and then dissolved in 10% ethanol to prepare an extract.

실험 1 : Experiment 1: 피부세포증식효과Skin cell proliferation effect

본 개시에 적용되는 해송이버섯 추출물이 피부 세포 증식에 미치는 효과를 알아보기 위하여, 인체 정상 섬유아세포(한국세포주은행)를 96웰 마이크로 플레이트(96-well microplate)의 각 웰에 1×104세포가 되도록 접종하고, DMEM 배지(Sigma사)에서 24시간 동안 37℃에서 배양하였다. To examine the effect of the mushroom extract on skin cell proliferation applied to the present disclosure, human normal fibroblasts (Korean Cell Line Bank) were inoculated into each well of a 96-well microplate at 1 x 10 4 cells , And cultured in DMEM medium (Sigma) for 24 hours at 37 ° C.

이어, 해송이버섯 추출물이 50 ~ 500㎍/㎖로 포함된 혈청이 없는 DMEM배지로 교체한 실험군과 해송이버섯 추출물이 포함되지 않은 혈청이 없는 DMEM배지로 교체한 대조군을 24시간 동안 추가 배양하였다. Then, the control group, which was replaced with serum-free DMEM medium containing 50 ~ 500 μg / ml of mushroom extract and a serum-free DMEM medium containing no mushroom extract, was further cultured for 24 hours .

그런 다음, MTT용액 (3-(4,5-디메틸티아졸-2-일) 2,5-디페닐테트라졸륨 브로마이드: 5㎎/㎖)을 각각 10㎕씩 첨가하고, 4시간 동안 배양한 후, 배지를 제거하고, 각 웰 당 100㎕의 DMSO용액을 가하여 20분 동안 진탕시키고, 마이크로플레이트 판독기(microplate reader, Molecular Devices, USA)를 이용하여 570nm에서 상층액의 흡광도를 측정하였다. Then, 10 μl of each of the MTT solution (3- (4,5-dimethylthiazol-2-yl) 2,5-diphenyltetrazolium bromide: 5 mg / ml) was added and cultured for 4 hours , And the medium was removed. 100 μl of DMSO solution was added to each well, shaken for 20 minutes, and the absorbance of the supernatant was measured at 570 nm using a microplate reader (Molecular Devices, USA).

측정값을 "세포증식효과(%)=[(실험군 흡광도-대조군의 흡광도)/대조군의 흡광도]×100"에 대입하여 세포증식효과를 산출하고, 그 결과는 하기 표 1에 나타내었다. The cell proliferation effect was calculated by substituting the measured values for "cell proliferation effect (%) = [(absorbance of experimental group - absorbance of control group) / absorbance of control group] × 100", and the results are shown in Table 1 below.

해송이버섯 추출물(㎍/㎖)Seaweed extract of mushroom (㎍ / ml) 세포증식효과 (%)Cell proliferation effect (%) 비 고Remarks 대조군Control group -- 5050 18.318.3 100100 38.238.2 200200 70. 570. 5 300300 75.975.9 500500 87.287.2

표 1을 참조하면, 해송이버섯 추출물을 처리하지 않은 대조군과 비교하여, 해송이버섯 추출물이 처리된 실험군은, 매우 높은 섬유아세포 증식효과를 나타내는 것을 확인할 수 있다.
As shown in Table 1, it can be seen that the test group treated with the extract of Mushroom extract showed a very high fibroblast proliferation effect compared with the control group treated with the mushroom extract.

실험 2 : 콜라겐 합성 증진 효과Experiment 2: Enhancement of collagen synthesis

인체 정상 섬유아세포 (한국세포주은행)를 96웰 마이크로플레이트의 각 웰에 2×104세포/웰이 되도록 접종하고, DMEM배지에서 37℃에서 24시간 동안 배양하였다. Human normal fibroblasts (Korean Cell Line Bank) were inoculated into each well of a 96-well microplate at 2 × 10 4 cells / well and cultured in DMEM medium at 37 ° C. for 24 hours.

이어, 해송이버섯 추출물이 50 ~ 500㎍/㎖로 포함된 혈청이 없는 DMEM배지로 교체한 실험군과 추출물이 포함되지 않은 혈청이 없는 DMEM배지로 교체한 대조군을 48시간 동안 추가로 배양하였다. Then, the control group was replaced with the serum-free DMEM medium supplemented with 50-500 μg / ml of the mushroom extract, and the control group was replaced with the serum-free DMEM medium containing no extract.

배양 후, 각 웰의 상층액을 모아 프로콜라겐(Procollagen)타입 IC-펩타이드(PICP)양을 키트(TAKARA, 일본)를 이용하여 측정함으로써 새로 합성된 콜라겐 양을 측정하였다. PICP양은 ng/2×104세포로 환산하였으며, 그 결과는 하기 표 2와 같다.After culturing, the supernatant of each well was collected and the amount of newly synthesized collagen was measured by measuring the amount of pro-collagen type IC-peptide (PICP) using a kit (TAKARA, Japan). The amount of PICP was converted into ng / 2 × 10 4 cells, and the results are shown in Table 2 below.

해송이버섯 추출물(㎍/㎖)Seaweed extract of mushroom (㎍ / ml) 콜라겐 합성량 (ng/2×104)Collagen synthesis amount (ng / 2 × 10 4 ) 비 고Remarks 대조군Control group 101101 5050 105105 100100 131131 200200 153153 300300 167167 500500 199199

표 2를 참조하면, 해송이버섯 추출물의 농도가 증가함에 따라 콜라겐의 합성이 증가함을 알 수 있고, 해송이버섯 추출물이 탁월한 콜라겐 합성 증진 효과를 나타냄을 알 수 있다.
As shown in Table 2, it can be seen that the synthesis of collagen increases with increasing concentration of mushroom extract, and that the mushroom extract of the sea bream exhibits an excellent collagen synthesis promoting effect.

실험 3 : Experiment 3: 콜라게나제Collagenase 억제 효과 Inhibitory effect

해송이버섯 추출물의 콜라게나제 생성 저해능을 측정하였다. The inhibitory effect on the collagenase production of the mushroom extract was measured.

실험은 2.5%의 우태아 혈청이 함유된 DMEM (Dulbeccomodified EagleMedia)배지가 함유된 96웰 평판배양기 (96-well micotiter plate)에 인간의 섬유아세포를 2×104세포/웰이 되도록 넣고, 70~80% 정도 자랄 때까지 배양하였다. Human fibroblasts were plated at 2 × 10 4 cells / well in a 96-well microtiter plate containing DMEM (Dulbeccomodified Eagle Media) medium containing 2.5% fetal bovine serum, And cultured until it grew to about 80%.

그리고 해송이버섯 추출물을 농도별로 24시간 동안 처리한 후, 세포배양액을 채위하였다. After the treatment, the mushroom extract was treated for 24 hours with concentration, and the cell culture liquid was dumped.

채위한 세포배양액을 상업적으로 이용 가능한 콜라게나제 측정기구 (미국 아머샴파마샤 사, Catalog # : RPN 2610)를 이용하여 콜라게나제 생성 정도를 측정하였다. The cell culture broth was measured for collagenase production using a commercially available collagenase measuring device (Amersham Pharmacia, Catalog #: RPN 2610).

먼저 1차 콜라게나제 항체가 균일하게 도포된 96웰 평판에 채위된 세포 배양액을 넣고 3시간 동안 항원-항체반응을 항온조에서 실시하였다. First, the cell culture medium, which had been plated on a 96-well plate uniformly coated with primary collagenase antibody, was added and the antigen-antibody reaction was performed in a thermostatic chamber for 3 hours.

3시간 후 발색단이 결합된 2차 콜라겐 항체를 96웰 평판에 넣고 다시 15분간 반응시켰다. After 3 hours, the second collagen antibody conjugated with chromophore was put into a 96-well plate and allowed to react for 15 minutes.

15분 후 발색유발물질을 넣어 실온에서 15분간 발색을 유도시키고, 다시 1M 황산을 넣어 발색반응을 중지시키면 반응액의 색깔은 노란색을 띄며 반응 진행의 정도에 따라 노란색의 정도가 다르게 나타난다. After 15 minutes, the color development induction substance is added and the color is induced at room temperature for 15 minutes. When the color reaction is stopped by adding 1 M sulfuric acid again, the color of the reaction solution is yellow and the degree of yellow is different according to the progress of the reaction.

노란색을 띄는 96웰의 흡광도를 흡광계를 이용하여 405nm에서 측정하고 콜라게나제의 합성 정도를 계산하였다. Absorbance of 96 wells in yellow was measured at 405 nm using a spectrophotometer and the degree of synthesis of collagenase was calculated.

해송이버섯 추출물을 처리하지 않은 군의 채위된 세포배양액의 반응 흡광도를 대조군으로 하였으며, 발현 저해능은 대조군의 합성능을 100으로 하여 대비한 결과는 표 3과 같다.The reaction absorbance of the cell cultures of the cells in which the mushroom extract was not treated was used as a control, and the expression inhibition was evaluated as 100 for the control performance of the control group.

해송이버섯 추출물(㎍/㎖)Seaweed extract of mushroom (㎍ / ml) 콜라게나제 발현정도 (%)Expression level of collagenase (%) 비 고Remarks 대조군Control group 100100 5050 9595 100100 8787 200200 8080 300300 7272 500500 6363

표 3을 참조하면, 해송이버섯 추출물의 농도가 증가할수록 세포에서의 콜라게나제 발현의 저해능이 증가됨을 확인할 수 있었다.
As shown in Table 3, it was confirmed that the inhibitory effect of collagenase expression in cells was increased as the concentration of mushroom extract increased.

실험 4 : 항산화효과Experiment 4: Antioxidant effect

본 개시에 적용되는 해송이버섯 추출물의 항산화효과를 알아보기 위하여 자유라디칼 소거활성실험 (Free Radical Scavenging Activity Test)을 실시하였다. Free Radical Scavenging Activity Test was conducted to examine the antioxidant effect of the mushroom extract applied to the present disclosure.

자유라디칼 소거활성 실험은 KIm 등 (Kor. J. Pharmacogn., 24(4), 299-303 (1993))의 방법을 변형한 것으로써, 안정한 자유라디칼인 DPPH (1,1-diphenyl-2-picryhydrazyl, Sigma사)시약을 사용하였다. 0.2mM DPPH용액 (Blank는 에탄올) 150㎕에 해송이버섯 추출물을 다양한 농도로 제작하여, 이들을 각각 150㎕씩 첨가하여 혼합하고, 실온에서 30분간 방치한 후 517nm에서 흡광도를 측정하는 실험군을 설정하였으며, 이에 대한 대조군으로는 정제수를 이용한 경우로 설정하였다. The free radical scavenging activity test was carried out by modifying the method of KIm et al. (Kor. J. Pharmacogn., 24 (4), 299-303 (1993)), and a stable free radical DPPH (1,1-diphenyl- picryhydrazyl, Sigma) reagents were used. 150 μl of 0.2 mM DPPH solution (Blank in ethanol) was added to 150 μl of each of the extracts of Haesong mushroom extract at various concentrations. After incubation at room temperature for 30 minutes, an experiment group was set up to measure the absorbance at 517 nm , And the control group was set to use purified water.

실험군과 대조군에 대한 흡광도 측정 후, "자유라디칼소거효과 (%)=100-[(실험군 흡광도- Blank 흡광도)/대조군의 흡광도]×100"에 대입하여 자유라디칼 소거활성 효과를 구하여 그 결과를 표 4에 나타내었다. After the measurement of the absorbance of the experimental group and the control group, the free radical scavenging effect (%) = 100 - [(absorbance of experiment group - absorbance of blank) / absorbance of control group] × 100 " Respectively.

해송이버섯 추출물(㎍/㎖)Seaweed extract of mushroom (㎍ / ml) 자유라디칼소거효과 (%)Free radical scavenging effect (%) 비 고Remarks 5050 10.110.1 100100 16.916.9 200200 35.235.2 300300 44.344.3 500500 74.474.4

표 4를 참조하면, 본 개시에 적용되는 해송이버섯 추출물은 그 농도가 증가할수록 자유라디칼 소거능력이 향상됨을 확인할 수 있다.
Referring to Table 4, it can be confirmed that the free radical scavenging ability of the mushroom extract applied to the present disclosure increases as the concentration thereof increases.

다음으로, 본 개시에 따른 화장료 조성물에 있어서, 해송이버섯 추출물의 함량이 피부에 미치는 효과에 대한 실험 결과를 설명한다.
Next, experimental results on the effect of the content of mushroom extract on the skin in the cosmetic composition according to the present disclosure will be described.

실험샘플의 제조Preparation of experimental samples

본 개시에 따른 해송이버섯 추출물이 함유된 화장료 조성물의 피부주름개선효과, 리프팅(피부탄력개선)효과를 알아보기 위해, 해송이버섯 추출물이 포함되지 않은 비교예 1, 해송이버섯 추출물이 0.1, 0.5, 3, 5, 7, 10, 13중량%로 각각 포함된 실시예 1,2,3,4,5,6,7을 제조하였으며, 각 실험샘플의 해송이버섯 추출물을 제외한 다른 조성은 표 5와 같다.In order to examine the skin wrinkle improving effect and lifting effect (skin elasticity improving effect) of the cosmetic composition containing the sea mushroom extract according to the present disclosure, Comparative Example 1 in which the sea mushroom extract was not included, 0.1 in the sea mushroom extract, 3, 4, 5, 6, and 7, respectively, containing 0.5, 3, 5, 7, 10, and 13% by weight of the mushroom extract, respectively. 5.

성분명Ingredients 함량 (중량%)Content (% by weight) 바셀린vaseline 7.07.0 유동파라핀Liquid paraffin 5.05.0 밀납Wax 2.02.0 폴리소르베이트 60Polysorbate 60 2.02.0 소르비탄세스퀴올레이트Sorbitan sesquioleate 2.52.5 스쿠알란Squalane 3.03.0 프로필렌글라이콜Propylene glycol 6.06.0 글리세린glycerin 4.04.0 트리에탄올아민Triethanolamine 0.50.5 카르복시비닐폴리머Carboxyvinyl polymer 0.50.5 토코페릴아세테이트Tocopheryl acetate 0.10.1 방부제/향Preservative / incense 적당량Proper amount 정제수Purified water To 100To 100

실험 5 : 피부주름개선효과Experiment 5: Skin wrinkle improvement effect

본 개시에 따른 해송이버섯 추출물을 함유하는 화장료 조성물의 피부주름개선효과를 건강한 35세에서 50세의 여성 80명을 대상으로 측정하였다. 먼저 그룹당 10명씩 8개의 그룹으로 나누고, 각각 실시예 1 내지 7 및 비교예 1의 화장료 조성물을 안면부에 하루 2회씩 (아침/저녁) 3개월간 도포하였다. The skin wrinkle improving effect of the cosmetic composition containing the mushroom extract according to the present disclosure was measured in 80 healthy women aged 35 to 50 years. First, the cosmetic composition of each of Examples 1 to 7 and Comparative Example 1 was applied to the face portion for 2 months (morning / evening) for 3 months.

3개월 후 주름의 개선 정도를 피험자의 설문 및 주름의 영상분석을 통해 평가하였다. After 3 months, the improvement of wrinkles was evaluated by image analysis of questionnaires and wrinkles.

피험자의 설문은 사용전과 비교하여 개선 없음, 약간의 개선, 중등도의 개선, 상당한 개선의 4단계로 판단하였으며 결과는 표 6과 같다.The subjects' questionnaires were judged to be four stages of no improvement, slight improvement, moderate improvement, and considerable improvement compared to before use. The results are shown in Table 6.

평가시료Evaluation sample 개선없음No improvement 약간의 개선Slight improvement 중등도의 개선Moderate improvement 상당한 개선A significant improvement 실시예 1Example 1 66 33 1One -- 실시예 2Example 2 1One 44 44 1One 실시예 3Example 3 1One 33 44 22 실시예 4Example 4 00 22 55 33 실시예 5Example 5 00 33 66 1One 실시예 6Example 6 1One 33 44 22 실시예 7Example 7 1One 44 33 22 비교예 1Comparative Example 1 77 33 -- --

표 6을 참조하면, 실시예 2 내지 7에서 만족할만한 결과가 얻어지고 있음을 확인할 수 있고, 실시예 4,5에서 가장 만족할만한 결과가 얻어지고 있음을 확인할 수 있다.Referring to Table 6, it can be confirmed that satisfactory results are obtained in Examples 2 to 7, and it can be confirmed that the most satisfactory results are obtained in Examples 4 and 5.

다음으로, 주름의 영상분석에 의한 평가는 실험이 시작되기 전 눈 밑의 레플리카를 채취하고 실험이 종료된 직후의 레플리카를 눈 밑의 동일 부위에서 채취하여 영상분석을 통해 주름의 2차원적 분석으로 주름의 밀도를 측정하였다. 영상분석에 의한 주름 밀도의 측정결과는 사용 전에 대한 주름 밀도에 대한 감소율로 표 7에 나타내었다. Next, the evaluation by image analysis of wrinkles was carried out by taking a replica under the eyes before the start of the experiment, collecting the replica immediately after the end of the experiment from the same area under the eyes, and performing a two-dimensional analysis The density of the wrinkles was measured. The results of the measurement of the wrinkle density by image analysis are shown in Table 7 as a reduction rate relative to the wrinkle density before use.

평가시료Evaluation sample 주름밀도감소율(%)Wrinkle density reduction rate (%) 비고Remarks 실시예 1Example 1 77 실시예 2Example 2 2828 실시예 3Example 3 3030 실시예 4Example 4 3535 실시예 5Example 5 3636 실시예 6Example 6 3535 실시예 7Example 7 3333 비교예 1Comparative Example 1 55

표 7을 참조하면, 표 6의 설문과 유사하게, 실시예 2 내지 7에서 만족할만한 결과가 얻어지고 있음을 확인할 수 있고, 실시예 4,5에서 가장 만족할만한 결과가 얻어지고 있음을 확인할 수 있다.
Referring to Table 7, it can be confirmed that satisfactory results are obtained in Examples 2 to 7 similarly to the questionnaire in Table 6, and it can be confirmed that the most satisfactory results are obtained in Examples 4 and 5 .

실험 6 : Experiment 6: 리프팅(피부탄력개선)효과Lifting (skin elasticity improvement) effect

본 개시에 따른 해송이버섯 추출물을 함유하는 화장료 조성물의 피부 탄력 증진효과를 측정하였다. 온도 24~26℃, 습도 75%의 조건에서 20세 이상의 건강한 여성 80명(평균연령 35세)을 8개의 그룹(그룹당 10명)으로 나누고, 각각 실시예 1 내지 7 및 비교예 1의 화장료 조성물을 눈가를 중심으로 하루 2회 (아침/저녁) 3개월간 도포한 후, 피부탄력측정기 (Cutometer MPA580, Conrage + Khazaka사, 독일)를 이용하여 피부탄력을 측정하였다. 시험결과는 Cutometer MPA580의 R5(R5(12주)-R5(0주))값으로 기재하였고, R5값은 피부의 순수탄성도 (Net elasticity)성질을 나타내며 1에 가까울수록 탄력도가 우수함을 나타낸다. 결과는 표 8과 같다.The skin elasticity-enhancing effect of the cosmetic composition containing the mushroom extract according to the present disclosure was measured. 80 healthy women aged 20 years or older (mean age 35 years) were divided into 8 groups (10 persons per group) under the conditions of temperature of 24 to 26 DEG C and humidity of 75%, and the cosmetic compositions of Examples 1 to 7 and Comparative Example 1 The skin elasticity was measured using a skin elasticity tester (Cutometer MPA580, Conrage + Khazaka, Germany) after applying for 2 months (morning / evening) for 3 months. The test result is described as R5 (R5 (12 weeks) -R5 (0 week)) value of Cutometer MPA580. R5 value shows the net elasticity property of the skin. The results are shown in Table 8.

평가시료Evaluation sample 피부탄력개선효과Skin elasticity improvement effect 비고Remarks 실시예 1Example 1 0.0150.015 실시예 2Example 2 0.0750.075 실시예 3Example 3 0.0820.082 실시예 4Example 4 0.0870.087 실시예 5Example 5 0.0850.085 실시예 6Example 6 0.0800.080 실시예 7Example 7 0.0810.081 비교예 1Comparative Example 1 0.0120.012

표 8을 참조하면, 본 개시에 따른 해송이버섯 추출물을 함유한 실시예 2 내지 7의 리프팅 (피부탄력개선) 효과는 비교예 1에 비해 약 525% ~ 725% 증가하였다. 따라서 해송이버섯 추출물을 함유하는 화장료는 리프팅(피부탄력개선) 효과를 효과적으로 증진시킴을 확인할 수 있다.
Referring to Table 8, the lifting (skin elasticity improving) effects of Examples 2 to 7 containing the mushroom extract according to the present invention were increased by about 525% to 725% as compared with Comparative Example 1. [ Therefore, it can be confirmed that the cosmetic composition containing the sea mushroom extract effectively improves the lifting effect (skin elasticity improvement).

Claims (5)

분자량이 200,000 ~ 500,000인 해송이버섯 추출물 0.5~10.0중량%를 함유하는 해송이버섯 추출물을 이용한 주름개선 및 피부 처짐 개선용 화장료 조성물.A cosmetic composition for improving wrinkles and skin defects by using a mushroom extract containing a mushroom extract having a molecular weight of 200,000 to 500,000 and containing 0.5 to 10.0% by weight of mushroom extract. 청구항 1에 있어서,
바셀린 7.0중량%, 유동파라핀 5.0중량%, 밀납 2.0중량%, 폴리소르베이트60 2.0중량%, 소르비탄세스퀴올레이트 2.5중량%, 스쿠알란 3.0중량%, 프로필렌글라이콜 6.0중량%, 글리세린 4.0중량%, 트리에탄올아민 0.5중량%, 카르복시비닐폴리머 0.5중량%, 토코페릴아세테이트 0.1중량% 및 정제수 55~65중량%을 포함하는 것을 특징으로 하는 해송이버섯 추출물을 이용한 주름개선 및 피부 처짐 개선용 화장료 조성물.
The method according to claim 1,
7.0 wt% of Vaseline, 5.0 wt% of liquid paraffin, 2.0 wt% of wax, 2.0 wt% of polysorbate 60, 2.5 wt% of sorbitan sesquioleate, 3.0 wt% of squalane, 6.0 wt% of propylene glycol, 4.0 wt% of glycerin, , 0.5% by weight of triethanolamine, 0.5% by weight of carboxyvinyl polymer, 0.1% by weight of tocopheryl acetate and 55% to 65% by weight of purified water.
청구항 1에 있어서,
상기 해송이버섯 추출물은,
건조된 해송이버섯을 설정된 극성 추출 용매에 30~70℃의 온도 및 5~20시간 동안 침적(submerge)하여 추출되는 것을 특징으로 하는 해송이버섯 추출물을 이용한 주름개선 및 피부 처짐 개선용 화장료 조성물.
The method according to claim 1,
The above-mentioned mushroom extract,
Wherein the dried sea cucumber is extracted by submerging the dried mushroom in a polarity extraction solvent set at a temperature of 30 to 70 ° C for 5 to 20 hours to improve wrinkles and skin defects.
청구항 3에 있어서,
상기 설정된 극성 추출 용매는, 상기 건조된 해송이버섯의 중량의 2~10배로 마련되는 것을 특징으로 하는 해송이버섯 추출물을 이용한 주름개선 및 피부 처짐 개선용 화장료 조성물.
The method of claim 3,
The cosmetic composition for improving wrinkles and skin defects using the extract of Mushroom mushroom according to claim 1, wherein the polar solvent for extracting polar solvent is 2 to 10 times the weight of the mushroom.
청구항 4에 있어서,
상기 설정된 극성 추출 용매는, 탄소수 1 내지 4의 저급 알코올, 정제수 또는 이들의 혼합물 중 어느 하나로 마련되는 것을 특징으로 하는 해송이버섯 추출물을 이용한 주름개선 및 피부 처짐 개선용 화장료 조성물.
The method of claim 4,
Wherein the polarity extraction solvent is one selected from the group consisting of lower alcohols having 1 to 4 carbon atoms, purified water, and mixtures thereof.
KR1020150020248A 2015-02-10 2015-02-10 Anti-wrinkle and anti-skin sagging cosmetic composition containing extracts of hypsizigus marmoreus KR101821738B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020150020248A KR101821738B1 (en) 2015-02-10 2015-02-10 Anti-wrinkle and anti-skin sagging cosmetic composition containing extracts of hypsizigus marmoreus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020150020248A KR101821738B1 (en) 2015-02-10 2015-02-10 Anti-wrinkle and anti-skin sagging cosmetic composition containing extracts of hypsizigus marmoreus

Publications (2)

Publication Number Publication Date
KR20160097854A true KR20160097854A (en) 2016-08-18
KR101821738B1 KR101821738B1 (en) 2018-01-24

Family

ID=56874330

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020150020248A KR101821738B1 (en) 2015-02-10 2015-02-10 Anti-wrinkle and anti-skin sagging cosmetic composition containing extracts of hypsizigus marmoreus

Country Status (1)

Country Link
KR (1) KR101821738B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020128991A1 (en) * 2018-12-21 2020-06-25 Covertis Biologically active substance, method for manufacturing same and use thereof as an agent for protecting a biological tissue
CN113582996A (en) * 2021-06-02 2021-11-02 韶关市星河生物科技有限公司 Application of hypsizigus marmoreus strain in preparation of folic acid

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020128991A1 (en) * 2018-12-21 2020-06-25 Covertis Biologically active substance, method for manufacturing same and use thereof as an agent for protecting a biological tissue
FR3090275A1 (en) * 2018-12-21 2020-06-26 Covertis BIOLOGICALLY ACTIVE SUBSTANCE, MANUFACTURING METHOD THEREOF AND USE THEREOF AS PROTECTIVE AGENT FOR BIOLOGICAL TISSUE
CN113582996A (en) * 2021-06-02 2021-11-02 韶关市星河生物科技有限公司 Application of hypsizigus marmoreus strain in preparation of folic acid
CN113582996B (en) * 2021-06-02 2024-02-06 韶关市星河生物科技有限公司 Application of hypsizigus marmoreus strain in preparation of folic acid

Also Published As

Publication number Publication date
KR101821738B1 (en) 2018-01-24

Similar Documents

Publication Publication Date Title
EP2859918A1 (en) Cosmetic composition containing fermented ginseng berry pleurotus ferulae product.
US9199101B2 (en) Use of a peptide hydrolysate of pea as moisturizing active agent
KR20070019120A (en) Anti-Wrinkle Cosmetic Composition Comprising the Extract of Paeonia lactiflora as Active Ingredient
KR101821738B1 (en) Anti-wrinkle and anti-skin sagging cosmetic composition containing extracts of hypsizigus marmoreus
KR20110076797A (en) Extract of the plant ravenala madagascariensis and use as cosmetic hydrating agent
KR101204858B1 (en) Cosmetic Composition for for improving Skin-Wrinkle
KR19990086516A (en) Anti-aging cosmetic composition containing ginseng extract
KR20080093500A (en) Cosmetic compositions for preventing skin aging comprising extract astilbe chinensis var. davidii
KR101805872B1 (en) Cosmetic composition for improving skin wrinkle containing plant extract removed chlorophyll
KR20120025244A (en) Cosmetic compositions for improving skin wrinkles comprising extract of camellia sasanqua
KR101042718B1 (en) Cosmetic compositions for preventing skin aging or whitening skin comprising extracts from Ficus erecta Thunb.
KR20040078498A (en) Cosmetic Composition for Enhancing Skin Elasticity Comprising Boswellia Extracts as Active Ingredient
KR100882744B1 (en) Manufacturing method of cometic compositions containing extract of paeonia suffruticosa andrew
KR20180050624A (en) Method for removing chlorophyll and pigments from plant extracts
KR101074132B1 (en) Cosmetic composition containing Salicornia herbacea callus extracts and Pelvetia Canaliculata extracts for improving skin wrinkle or enhancing elasticity
KR100702330B1 (en) Cosmetic Composition for Inhibition of Skin Aging Comprising the Extract of Areca catechu and Synthetic Palmitoylpentapeptide as an Active Ingredient
KR20180088173A (en) A cosmetic composition comprising extracts of cladosiphon novae - caledoniae kylin
KR20050038112A (en) Anti-wrinkle cosmetic composition containing extracts of inonotus obliquus
KR101008833B1 (en) cosmetic compositions containing extract of Sorbus alnifolia S. et Z. K. Koch used for antiwrinkle
KR20080098925A (en) Cometic compositions containing extract of paeonia suffruticosa andrew
KR100713557B1 (en) Cosmetic composition for skin whitening comprising ramulus mori extract and hexanoyl-tripeptide as active ingredient
KR102597794B1 (en) Composition for improving skin condition comprising epidermal growth factor and extract of aronia melanocarpa fruit
KR102315426B1 (en) Cosmetic composition for pad comprising natural extracts
KR100967805B1 (en) cosmetic compositions containing extract of Ostrya japonica Sarg used for antiwrinkle
KR20090097232A (en) Cosmetic compositions containing extract of viburnum dilatatum thunb used for antiwrinkle

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant